Andrew Krakauer, CEO of Cantel Medical added, I am very impressed with the employees, operations, and high service-orientation of ConFirm. We are delighted that Mark Frampton shall continue as the general manager for at least the first year. .. Cantel Medical acquires ConFirm’s sterilization monitoring business CANTEL MEDICAL CORP. , through its Crosstex International subsidiary, has further expanded its an infection control and prevention business by purchasing the sterilization monitoring business of ConFirm Monitoring Systems, Inc.0 million in GAAP sales, the privately-held enterprise was founded 10 years ago and conducts over two million tests per year.5 million in cash at closing and contingent consideration of up to an additional $1.through January 31 0 million based on achievement of specified sales levels, 2012.ASLAN will run and fund development of BMS-777607 under a pre-agreed development program which will initially target gastric malignancy and lung malignancy. Financial terms weren’t disclosed. Related StoriesMD Anderson study reveals why chemotherapy medicines not effective for many pancreatic cancer patientsNew antenna-like device makes breast cancer medical procedures easier for surgeonsStudy displays rare HER2 missense mutations usually do not spread breasts cancer on their own This ground-breaking partnership demonstrates what sort of leading Asian drug development company could work together with a worldwide biopharmaceutical firm to accelerate drug advancement and conduct early scientific studies in Asia in areas of significant unmet need, said Dr.